 Connection
David Price to Antidepressive Agents
This is a "connection" page, showing publications David Price has written about Antidepressive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.480 |
|
|
|
-
de Groot M, Marrero D, Mele L, Doyle T, Schwartz F, Mather KJ, Goldberg R, Price DW, Ma Y, Knowler WC. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program. Psychosom Med. 2018 Feb/Mar; 80(2):167-173.
Score: 0.133
-
Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study. Psychosom Med. 2015 Apr; 77(3):303-10.
Score: 0.109
-
Price DW, Ma Y, Rubin RR, Perreault L, Bray GA, Marrero D, Knowler WC, Barrett-Connor E, Lacoursiere DY. Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. Diabetes Care. 2013 Feb; 36(2):216-21.
Score: 0.092
-
Rubin RR, Ma Y, Peyrot M, Marrero DG, Price DW, Barrett-Connor E, Knowler WC. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care. 2010 Dec; 33(12):2549-51.
Score: 0.080
-
Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008 Mar; 31(3):420-6.
Score: 0.066
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|